Page last updated: 2024-11-05

ticlopidine and Esophageal Neoplasms

ticlopidine has been researched along with Esophageal Neoplasms in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scholl, S1
Dellon, ES1
Shaheen, NJ1
Greenspan, NR1

Other Studies

2 other studies available for ticlopidine and Esophageal Neoplasms

ArticleYear
Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:3

    Topics: Adenocarcinoma; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aspirin; Barrett Esop

2011
Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Medicine and health, Rhode Island, 2011, Volume: 94, Issue:4

    Topics: Adenocarcinoma; Clopidogrel; Drug Industry; Drug Interactions; Endoscopy, Gastrointestinal; Esophage

2011